What is the treatment regimen for fingernail fungal infections using Edfinaconazole (generic name: Edfinaconazole)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Efinaconazole Treatment Regimen for Fingernail Fungal Infections

For fingernail fungal infections, efinaconazole 10% topical solution should be applied once daily directly to the affected fingernails for approximately 36-40 weeks. 1, 2

Efficacy and Indications

  • Efinaconazole 10% topical solution is FDA-approved for onychomycosis in patients aged 6 years and above, with demonstrated efficacy for fingernail infections 3
  • Efinaconazole exhibits higher in vitro activity against dermatophytes than other topical antifungals like ciclopirox and itraconazole, with activity comparable to amorolfine and terbinafine 3
  • Efinaconazole provides enhanced nail penetration compared to other topical antifungals due to its low surface tension, poor water solubility, and low keratin affinity 3
  • In clinical studies, fingernail infections treated with efinaconazole for a mean duration of 38.7 weeks showed significant improvement, with an 80% improvement rate 1

Application Instructions

  • Apply efinaconazole 10% solution directly to the affected fingernail(s) once daily 1, 2
  • Ensure the nail and surrounding area are clean and dry before application 3
  • Use the applicator to apply the solution to the entire nail surface and undersurface of the nail plate where accessible 3
  • Allow the solution to dry completely before touching or washing the treated area 3
  • Continue treatment until clinical improvement is observed, typically for 36-40 weeks for fingernail infections 1, 2

Patient Selection Considerations

  • Efinaconazole is particularly recommended as first-line therapy for:
    • Mild-to-moderate onychomycosis 3
    • Patients with liver or kidney disease who cannot take oral antifungals 3, 2
    • Patients with certain autoimmune conditions like scleroderma where oral antifungals may be contraindicated 2
    • Patients taking medications that interact with oral antifungals 2

Treatment Outcomes and Expectations

  • Patients should be informed that complete cure takes time due to the slow growth rate of nails 4
  • Factors associated with better response include:
    • Female gender
    • Lower BMI
    • Mild onychomycosis
    • Short disease duration
    • Treatment of concomitant fungal infections 3
  • Mycological cure rates are typically about 30% better than clinical cure rates 4

Monitoring and Side Effects

  • Monitor for application site reactions, which are the most common side effects:
    • Ingrown nails
    • Dermatitis
    • Vesicles
    • Pain at application site 3
  • These side effects are typically mild and resolve upon discontinuation of treatment 5

Important Caveats

  • Confirm diagnosis with mycological examination (direct microscopy and culture) before initiating treatment 6, 7
  • Treatment failure is common with incorrect diagnosis made on clinical grounds alone 7
  • While oral antifungals like terbinafine and itraconazole generally have higher efficacy rates for onychomycosis, topical efinaconazole is a valuable alternative for patients who cannot tolerate or have contraindications to oral therapy 6, 7, 2
  • Consider longer treatment durations for elderly patients, those with more severe infections, or mixed infections (dermatophyte plus non-dermatophyte molds) 8

References

Research

Efinaconazole in Onychomycosis.

American journal of clinical dermatology, 2022

Guideline

Onychomycosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Onychomycosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.